About this trial
This study aims to evaluate the effectiveness of a large language model (LLM)-supported, community-based integrated management model in improving cardiometabolic multimorbidity control among adults with hypertension and coexisting diabetes or dyslipidemia. Adopting an interventional study design, eligible patients will be recruited to compare the disease control indicators between LLM-assisted management and conventional management, so as to verify the effectiveness and safety of the former.
Eligibility criteria
Qualifiers
Have a designated community physician responsible for primary care who is capable of using a smartphone with stable internet access for clinical communication and LLM-assisted management;
No plan for administrative merger or restructuring within the next three years;
Located at least 2 kilometers away from adjacent participating communities (to minimize contamination between clusters).
Aged 40 years or older;
Disqualifiers
None
Trial design
Treatments tested in this trial
- LLM-Enabled Co-management
Treatment groups
Sponsors and collaborators
First Hospital of China Medical University
Lead sponsor
Beijing Chao Yang Hospital
Collaborator
Zhejiang University
Collaborator
Shandong Provincial Hospital
Collaborator
Cangzhou Central Hospital
Collaborator